[HTML][HTML] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - Oncotarget, 2012 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[PDF][PDF] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - core.ac.uk
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[PDF][PDF] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - researchgate.net
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[引用][C] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

M Cervello, J Mccubrey, A Cusimano, N Lampiasi… - ONCOTARGET, 2012 - iris.unipa.it
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. IRIS IRIS Home
Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione Riviste Serie Tipologia IT …

[引用][C] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - Oncotarget, 2012 - cir.nii.ac.jp
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

Targeted therapy for hepatocellular carcinoma: Novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - 2012 - thescholarship.ecu.edu
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[HTML][HTML] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - Oncotarget, 2012 - oncotarget.com
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon | Oncotarget Online
ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission Current Volume …

[PDF][PDF] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …

[PDF][PDF] Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

M Cervello, JA McCubrey, A Cusimano, N Lampiasi… - Oncotarget, 2012 - scienceopen.com
Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of
primary liver cancers. In the last decade it has become one of the most frequently occurring …